The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

Kennedy testified before the House Energy and Commerce Health Subcommittee about health spending cuts and health agency ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

MIT and Scripps scientists explore a single-dose vaccine approach by combining two immune-boosting ingredients.

But one of the standout moments during the hearing occurred when Kennedy suggested that a sitting member of Congress only ...

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

For nearly 15 years, Dennis Burton worked on a project aimed at solving what he calls "one of the most difficult problems in ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...